Dee Shortridge

3.6k citations

85 papers · 2.6k indexed · 1 hit paper · h-index 29

Impact in

Applied Microbiology and Biotechnology top 0.2%
- Antibiotic Use and Resistance
Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 36
- Antibiotic Use and Resistance 36
Molecular Medicine 58
- Antibiotic Resistance in Bacteria 58

Co-authors: Robert K. Flamm Michael A. Pfaller Mariana Castanheira Hélio S. Sader Rodrigo E. Mendes Jill Beyer Shinji Tanaka James Versalovic
Journals: Open Forum Infectious Diseases (20 papers)Antimicrobial Agents and Chemotherapy (15 papers)Journal of Clinical Microbiology (7 papers)Diagnostic Microbiology and Infectious Disease (6 papers)International Journal of Antimicrobial Agents (4 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Dee Shortridge

82 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori 1996 · 407 citations

Peers

Countries citing papers authored by Dee Shortridge

Since Specialization

Citations

This map shows the geographic impact of Dee Shortridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dee Shortridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dee Shortridge more than expected).

Fields of papers citing papers by Dee Shortridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dee Shortridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dee Shortridge. The network helps show where Dee Shortridge may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dee Shortridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dee Shortridge Line = papers co-authored together Dee Shortridge links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	734. Trend Analysis of Oritavancin and Comparator Agents Activity against Enterococcus Causing Infections in US Medical Centers between 2017–2019 and 2022 Open Forum Infectious Diseases ·Cecília G Carvalhaes, Rodrigo E. Mendes, Dee Shortridge, Mariana Castanheira	2023	0
2	Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020–2021) International Journal of Antimicrobial Agents ·Hélio S. Sader, Rodrigo E. Mendes, S J Ryan Arends, Cecília G Carvalhaes, Dee Shortridge, Mariana Castanheira	2023	14
3	Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016–2018) Infection and Drug Resistance ·Michael A. Pfaller, Dee Shortridge, Wei‐Ting Chen, Hélio S. Sader, Mariana Castanheira	2022	6
4	Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018–2020) European Journal of Clinical Microbiology & Infectious Diseases ·Hélio S. Sader, Mariana Castanheira, Michael D. Huband, Dee Shortridge, Cecília G Carvalhaes, Rodrigo E. Mendes	2022	9
5	Activity of Ceftolozane-Tazobactam Against Gram-Negative Isolates from Australia and New Zealand as part of the PACTS Surveillance 2016-2018 Journal of Global Antimicrobial Resistance ·Dee Shortridge, Jennifer M Streit, Michael A. Pfaller, Anselmo Sánchez Ferra, Wei‐Ting Chen, Mariana Castanheira	2022	3
6	Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018 International Journal of Infectious Diseases ·Michael A. Pfaller, Dee Shortridge, 辛志凤, Mark W. Garrison, C Andrew DeRyke, Daryl D. DePestel, Pamela Moise, Hélio S. Sader	2021	15
7	Antimicrobial performance of two preoperative skin preparation solutions containing iodine and isopropyl alcohol American Journal of Infection Control ·Muhammad Hamid Bashir, 耕一泊, Jennifer D. Thompson, Dee Shortridge, Spencer P. Lake, Corey R. Deeken, И.М. Лифшиц, L. Michel Paradis, Lingzhi Li, Maya P. Singh, Alexandre TROFINO Neto	2021	7
8	Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019 Journal of Global Antimicrobial Resistance ·Michael A. Pfaller, Michael D. Huband, Dee Shortridge, Robert K. Flamm	2021	21
9	Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020 European Journal of Clinical Microbiology & Infectious Diseases ·Hélio S. Sader, Cecília G Carvalhaes, Dee Shortridge, Mariana Castanheira	2021	13
10	Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016–2017) Diagnostic Microbiology and Infectious Disease ·Michael A. Pfaller, Robert K. Flamm, Leonard R Duncan, Dee Shortridge, Jennifer I. Smart, Kamal Hamed, Rodrigo E. Mendes, Hélio S. Sader	2019	22
11	Antimicrobial activity of ceftolozane–tazobactam tested against gram-negative contemporary (2015–2017) isolates from hospitalized patients with pneumonia in US medical centers Diagnostic Microbiology and Infectious Disease ·Cecília G Carvalhaes, Mariana Castanheira, Hélio S. Sader, Robert K. Flamm, Dee Shortridge	2018	42
12	Activity of fosfomycin when tested against US contemporary bacterial isolates Diagnostic Microbiology and Infectious Disease ·Robert K. Flamm, Paul R. Rhomberg, Amy A. Watters, A.P.F. Plaza-Faverola, Evelyn J. Ellis‐Grosse, Dee Shortridge	2018	19
13	Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa International Journal of Antimicrobial Agents ·Magali Jaillard, Alex van Belkum, Kyle C. Cady, David Creely, Dee Shortridge, Liang Bai-hui, E. Magda Barbu, W. Michael Dunne, Gilles Zambardi, Mark C. Enright, Nathalie Mugnier, David D. Feuer, Stéphane Schicklin, Ghislaine Guigon, Jean‐Baptiste Veyrieras	2017	45
14	Ceftolozane–tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013–2015) Journal of Global Antimicrobial Resistance ·Michael A. Pfaller, Dee Shortridge, Hélio S. Sader, Robert K. Flamm, Mariana Castanheira	2017	21
15	Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015) International Journal of Antimicrobial Agents ·Michael A. Pfaller, Dee Shortridge, Hélio S. Sader, Mariana Castanheira, Robert K. Flamm	2017	40
16	Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015 Antimicrobial Agents and Chemotherapy ·Mariana Castanheira, Leonard R Duncan, Rodrigo E. Mendes, Hélio S. Sader, Dee Shortridge	2017	50
17	International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests European Journal of Clinical Microbiology & Infectious Diseases ·David Creely, Gilles Zambardi, Alex van Belkum, W. Michael Dunne, Portia Okyere, Esteban Hernandez Londoño, Dee Shortridge, Victoria Nguyen	2013	7
18	Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in???an Era of Drug-Resistant Streptococcus pneumoniae Clinical Drug Investigation ·Pablo Bonvehí, H HERBST, Todd Busman, Dee Shortridge, Gerard Notario	2003	12
19	PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin Epidemiology and Infection ·Gregory G. Stone, Dee Shortridge, Robert K. Flamm, Jill Beyer, David Stamler, Shinji Tanaka	1997	13
20	Identification of a 23S rRNA Gene Mutation in Clarithromycin‐Resistant Helicobacter pylori Helicobacter ·Gregory G. Stone, Dee Shortridge, Robert K. Flamm, James Versalovic, Jill Beyer, Ken B. Idler, María Espinar Jiménez, Shinji Tanaka	1996	78

About Dee Shortridge

Dee Shortridge is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Pharmacology and Endocrinology, having authored 85 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (58 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers), Antibiotic Use and Resistance (36 papers), Antimicrobial Resistance in Staphylococcus (24 papers), Bacterial Identification and Susceptibility Testing (21 papers), Pneumonia and Respiratory Infections (13 papers), Infections and bacterial resistance (7 papers) and Nosocomial Infections in ICU (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (542 citations), Molecular Medicine (1.3k citations), Small Animals (417 citations), Clinical Biochemistry (368 citations) and Pharmacology (800 citations). Dee Shortridge has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Robert K. Flamm, Michael A. Pfaller, Mariana Castanheira, Hélio S. Sader, Rodrigo E. Mendes, Jill Beyer, Shinji Tanaka, James Versalovic, Michael D. Huband and David Y. Graham. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact